Remington Nevin, MD, MPH, DrPH
Consultant Physician Epidemiologist
Board Certified in Public Health & General Preventive Medicine and in
Occupational Medicine by the American Board of Preventive Medicine and
Certified in Public Health by the National Board of Public Health Examiners
Dr. Remington Nevin is a Vermont-based consultant physician epidemiologist board certified in Public Health and General Preventive Medicine and in Occupational Medicine by the American Board of Preventive Medicine and certified in public health by the National Board of Public Health Examiners.
A former U.S. Army Major and Preventive Medicine Officer and faculty associate in the Department of Mental Health at the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland, Dr. Nevin now serves as Executive and Medical Director of the Vermont-based Quinism Foundation.
Dr. Nevin's research has focused primarily on the the adverse effects of antimalarial drugs, including mefloquine (marketed as Lariam®), tafenoquine (marketed as Krintafel®, Kodatef®, and Arakoda™), chloroquine, and hydroxychloroquine.
Dr. Nevin’s work has been instrumental in improving policymakers’ understanding of the potential for long-lasting and permanent neurologic and psychiatric effects from quinoline antimalarials, as exemplified by the FDA "black box" warning for mefloquine.
Dr. Nevin has testified before the U.S. Senate, the Australian Senate, the U.K. Parliament, and the Canadian Parliament, and has provided evidence to the Irish Department of Defence on the drug’s lasting neurologic and psychiatric adverse effects confounding the diagnosis and management of posttraumatic stress disorder and traumatic brain injury. Dr. Nevin's work has contributed directly to militaries in the U.S., Canada, the U.K., and Ireland discontinuing their decades-long policies of first-line use of mefloquine, in favor of safer and better-tolerated alternatives.
Dr. Nevin was first to publish a clinical description of quinism, the permanent disorder of brain and brainstem dysfunction caused by the use of mefloquine and related quinoline drugs, and to publish descriptions of certain of its features, including limbic encephalopathy and neurotoxic vestibulopathy. Dr. Nevin has also collaborated on the first review of mefloquine’s adverse effects published in the forensic psychiatry literature, and published the first case report of a U.S. military veteran awarded service-related disability compensation for long-lasting adverse psychiatric effects from the drug.
Dr. Nevin has successfully aided attorney clients in the U.S., Canada, Australia, New Zealand, and the European Union in reaching favorable settlements in cases involving claims of central nervous system injury and other adverse effects from antimalarial drugs.
Dr. Nevin is also available for plaintiff and defense medicolegal consultation for cases involving other areas of occupational medicine, public health and preventive medicine, and epidemiology, and is also pleased to offer his services in preparing authoritative nexus letters and independent medical opinion reports for veterans seeking VA disability compensation for injuries and illnesses arising from their military service.
You can learn more about Dr. Nevin's services, contact Dr. Nevin directly for more information, or schedule a free initial consultation at no obligation.